Exploring the mode of action of ebselen in Trypanosoma brucei hexokinase inhibition

Bayer, 1985, 3-(N-Maleimido-propionyl)biocytin: a versatile thiol-specific biotinylating reagent, Anal. Biochem., 149, 529, 10.1016/0003-2697(85)90609-8 Borges, 2005, Effect of diphenyl diselenide, diphenyl ditelluride and ebselen on cerebral Na(+), K(+)-ATPase activity in rats, Toxicology, 215, 191, 10.1016/j.tox.2005.07.002 Brun, 2010, Human African trypanosomiasis, Lancet, 375, 148, 10.1016/S0140-6736(09)60829-1 Chambers, 2008, The anti-trypanosomal agent lonidamine inhibits Trypanosoma brucei hexokinase 1, Mol. Biochem. Parasitol., 158, 202, 10.1016/j.molbiopara.2007.12.013 Chambers, 2008, Assembly of heterohexameric trypanosome hexokinases reveals that hexokinase 2 is a regulable enzyme, J. Biol. Chem., 283, 14963, 10.1074/jbc.M802124200 Chambers, 2008, Residues in an ATP binding domain influence sugar binding in a trypanosome hexokinase, Biochem. Biophys. Res. Commun., 365, 420, 10.1016/j.bbrc.2007.10.192 Dodson, 2010, Quercetin, a fluorescent bioflavanoid, inhibits Trypanosoma brucei hexokinase 1, Exp. Parasitol., 127, 423, 10.1016/j.exppara.2010.10.011 Harris, 2013, Interrogating a hexokinase-selected small molecule library for inhibitors of Plasmodium falciparum hexokinase, Antimicrob. Agents Chemother., 57, 3717, 10.1128/AAC.00662-13 Lu, 2013, Inhibition of bacterial thioredoxin reductase: an antibiotic mechanism targeting bacteria lacking glutathione, FASEB J., 27, 1394, 10.1096/fj.12-223305 Lu, J., Vodnala, S.K., Gustavsson, A.L., Gustafsson, T.N., Sjoberg, B., Johansson, H.A., Kumar, S., Tjernberg, A., Engman, L., Rottenberg, M.E., Holmgren, A., in press. Ebsulfur is a benzisothiazolone cytocidal inhibitor targeting the trypanothione reductase of Trypanosoma brucei. J. Biol. Chem. http://dx.doi.org/jbc.M113.495101 Misset, 1984, Simultaneous purification of hexokinase, class-I fructose-bisphosphate aldolase, triosephosphate isomerase and phosphoglycerate kinase from Trypanosoma brucei, Eur. J. Biochem., 144, 475, 10.1111/j.1432-1033.1984.tb08490.x Misset, 1986, Glycolytic enzymes of Trypanosoma brucei. Simultaneous purification, intraglycosomal concentrations and physical properties, Eur. J. Biochem., 157, 441, 10.1111/j.1432-1033.1986.tb09687.x Morris, 2006, Activity of a second Trypanosoma brucei hexokinase is controlled by an 18-amino-acid C-terminal tail, Eukaryot. Cell, 5, 2014, 10.1128/EC.00146-06 Sakurai, 2006, Ebselen, a seleno-organic antioxidant, as an electrophile, Chem. Res. Toxicol., 19, 1196, 10.1021/tx0601105 Schewe, 1995, Molecular actions of ebselen – an antiinflammatory antioxidant, Gen. Pharmacol., 26, 1153, 10.1016/0306-3623(95)00003-J Sharlow, E., Golden, J.E., Dodson, H., Morris, M., Hesser, M., Lyda, T., Leimgruber, S., Schroeder, C.E., Flaherty, D.P., Weiner, W.S., Simpson, D., Lazo, J.S., Aube, J., Morris, J.C., 2010a. Identification of Inhibitors of Trypanosoma brucei Hexokinases, Probe Reports from the NIH Molecular Libraries Program, Bethesda (MD). Sharlow, 2010, A target-based high throughput screen yields Trypanosoma brucei hexokinase small molecule inhibitors with antiparasitic activity, PLoS Negl. Trop. Dis., 4, e659, 10.1371/journal.pntd.0000659 Terentis, 2010, The selenazal drug ebselen potently inhibits indoleamine 2,3-dioxygenase by targeting enzyme cysteine residues, Biochemistry, 49, 591, 10.1021/bi901546e Yamaguchi, 1998, Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group, Stroke, 29, 12, 10.1161/01.STR.29.1.12